Historical record - last NADAC publication: 9/22/2016

Product Information

TEMODAR 5 MG CAPSULE is a brand product labeled by Merck Sharp & Dohme LLC, priced at $17.1708 per EA under NDC 00085300403. Its NADAC has been published 146 times since Dec 18, 2013.

The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TEMODAR 5 MG CAPSULE

Temozolomide
$17.1708per EA
High Outlier

Strength

5 mg/1

NDC

00085300403

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

9/22/2016

Active Ingredients

TEMOZOLOMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021029

On Market Since

8/11/1999

Pharmacological Classes

Alkylating Activity
Alkylating Drug

Price Statistics

The NADAC for TEMODAR 5 MG CAPSULE has been published 146 times since Dec 18, 2013, and over the history we have for it it has risen 94.5%. The table below summarizes its recorded NADAC range and movement.

Current price$17.1708 per EA
All-time high$17.1708 (Sep 28, 2016)
All-time low$8.5105 (Jan 22, 2014)
Median price$13.8567
Average price$13.5717
Largest weekly change+29.9% (Jan 29, 2014)
Weeks tracked146
Tracking sinceDec 18, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+94.5%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TEMODAR 5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TEMODAR 5 MG CAPSULE, manufactured by Merck Sharp & Dohme LLC, is $17.1708 per EA (NDC 00085300403), effective Sep 28, 2016.

How has the price of TEMODAR 5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TEMODAR 5 MG CAPSULE has risen 94.5%. It has been tracked across 146 weekly CMS publications since Dec 18, 2013.

What are the highest and lowest recorded NADAC prices for TEMODAR 5 MG CAPSULE?

Since Dec 18, 2013, the NADAC for TEMODAR 5 MG CAPSULE has ranged from a low of $8.5105 (Jan 22, 2014) to a high of $17.1708 (Sep 28, 2016), with a median of $13.8567 per EA.

Are there cheaper alternatives to TEMODAR 5 MG CAPSULE?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 5 MG CAPSULE, is $1.9313 per EA — about 89% below TEMODAR 5 MG CAPSULE.

Who manufactures TEMODAR 5 MG CAPSULE?

TEMODAR 5 MG CAPSULE (NDC 00085300403) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.